LSL Pharma Group Inc. - Neraca (Quarterly)

LSL Pharma Group Inc.
CA ˙ TSXV ˙ CA50190N1042
CA$ 0.38 ↑0.01 (1.33%)
2025-09-05
BAHAGING PRESYO
Talaan ng Balanse (Quarterly)

Neraca LSL Pharma Group Inc. menunjukkan saldo akun perusahaan pada titik waktu tertentu. Data Neraca meliputi Aset, Aset Lancar, Aset Tetap, Properti, Pabrik dan Peralatan (PPE), Persediaan, Aset Tak Berwujud, Kewajiban, Kewajiban Lancar, Utang, Kewajiban Sewa Modal, Saham Biasa, Laba Ditahan, Saham Perbendaharaan, dan Ekuitas Pemegang Saham.

Semua angka adalah kelipatan 1,000,000.00 kecuali unit per saham.

2020
10-03
2020
12-31
2021
12-31
2022
09-30
2023
06-30
2024
06-30
2024
09-30
2024
12-31
2025
06-30
Cash 0 2 1 0 1 0 0 0 5
Change (%) 316.66 -61.52 -88.85 521.39 -43.73 -43.25 80.49 1,578.72
Assets Current 4 7 6 6 7 10 10 15 23
Change (%) 66.21 -0.54 -8.65 14.52 45.79 -0.07 55.79 51.03
Assets 24 27 29 29 30 37 38 54 62
Change (%) 14.28 6.79 -0.12 1.95 25.00 2.72 40.98 15.49
Liabilities 16 17 18 20 19 17 18 29 37
Change (%) 3.30 6.38 13.59 -6.56 -8.08 0.61 62.72 30.70
Equity 7 10 11 9 11 19 20 25 24
Change (%) 38.21 7.46 -22.22 21.99 84.66 4.62 22.21 -1.98
Liabilities And Stock Equity 24 27 29 29 30 37 38 54 62
Change (%) 14.28 6.79 -0.12 1.95 25.00 2.72 40.98 15.49

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista